Simply fill out the form with your details to gain access to recent podcasts and a sampling of previous PharmaForce conference audio presentations from Pharmaceutical and Biotechnology industry leaders.
|
|
|
Kent Rogers, Senior Director, Managed Markets, Acorda Therapeutics on comparative effectiveness and selling in third and specialty tiers.
Amid tightening regulations and comparative effectiveness, it’s becoming more difficult for pharmaceutical companies to present the value of their products and achieve favorable access to physicians (and effectively end users). Hear Kent’s thoughts about how sales forces are changing amid these challenges and how the industry as a whole is tackling the unavoidable (and shrinking) donut hole.
|
|
|
|
|
Liz Cermak, EVP and Chief Commercial Officer, Pozen discusses why digital & social media will change Healthcare & Pharma...forever
A recent survey of physicians which asked whether social media would change pharmaceutical marketing forever found 1/3 of physicians saying yes, it will within two years, and another 1/3 saying yes, it will within five years. This is -- according to Liz Cermak, EVP and Chief Commercial Officer, Pozen, who has put a great deal of focus on digital media – where she sees a lot of potential for pharmaceutical marketing in the years to come.“The representative as we know it who tries to do everything today, will probably not exist in its current form,” she says. In the podcast interview below, she explains how there will be a need for two types of people in the future, along with digital communication components. Listen for her insights as well as the number one piece of advice she has for any pharma organization, big or small, that wants to integrate social media into the marketing mix.
|
|
|
|
|
Norbert Stone, National Senior Director, Sales and Marketing Training and Development, Astellas Pharmaceuticals
Interview with WBR 7/29/2010 Norbert Stone talks pharmaceutical sales training in today's challenging pharma environment. He also answers:
How do we increase clinical and disease state acumen of our reps? How do we meet guidelines of states with regards to regulation?* Astellas is leveraging its virtual technologies, such as brain shark, virtual classrooms, etc.
* Limitations of technologies include bandwidth – typically there is limited bandwidth on IT systems, Internet, etc.
* With technology, there is always something to fit everyone’s budget. Astellas has a small budget so they work with new vendors and try to be creative
|
|
|
|
|
Sam Rasty, Director of Corporate Development at Endo Pharmaceuticals
Sam Rasty, Director of Corporate Development at Endo Pharmaceuticals, talks to Kelly Hushin, Online Content Manager for Worldwide Business Research, producers of PharmaForce, about healthcare reform, industry consolidation, M&A and business development for the pharmaceutical industry in 2010 and beyond.
|
|
|
|
|
Mike Capaldi, Associate Vice President, Sales Training & Leadership Development, Sanofi-Aventis
|
|
|
|
|
Ramesh Krishnan, Sr. Director, Marketing Science, Wyeth Pharmaceuticals
|
|
|
|
|
Rore Middleton, Corporate Compliance Associate, Purdue
|
|